Advertisement

Topics

Top investor slashes Moderna’s valuation as company struggles to live up to its own hype

17:33 EDT 28 Jun 2017 | STAT

One of Moderna Therapeutics’ largest investors slashed its assessment of the company’s value by 34 percent, a painful write-down for the ambitious biotech.

Original Article: Top investor slashes Moderna’s valuation as company struggles to live up to its own hype

NEXT ARTICLE

More From BioPortfolio on "Top investor slashes Moderna’s valuation as company struggles to live up to its own hype"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...